ROBERT ROSS: Open Payments
NPI 1023723715 · GOOSE CREEK, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,427 in 50 payments from 21 companies in 2025. Trend: 2023 $1,136 · 2024 $1,708 · 2025 $1,427
Food & beverage: $1,427
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $195 |
| Otsuka America Pharmaceutical, Inc. | 7 | $184 |
| AstraZeneca Pharmaceuticals LP | 6 | $150 |
| Lilly USA, LLC | 2 | $144 |
| Cagent Vascular INC | 1 | $144 |
| Corcept Therapeutics | 5 | $116 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $78 |
| PFIZER INC. | 3 | $67 |
| ABBVIE INC. | 3 | $55 |
| ACADIA Pharmaceuticals Inc | 2 | $53 |
Products named: REXULTI, Serrantor, Ozempic, Korlym, CAPLYTA, AIRSUPRA, FARXIGA, NUPLAZID.
Industry payments across SC — which companies pay providers there.
